Compile Data Set for Download or QSAR
Report error Found 106 Enz. Inhib. hit(s) with all data for entry = 9374
TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461986BDBM461986(17-methyl-N-(pyrazin-2-yl)morphinan-3-amine | US1...)
Affinity DataIC50: 5nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461936BDBM461936(3-hydroxy-17-(2-methoxyethyl)morphinan-6-one | US...)
Affinity DataIC50: 5nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 462016BDBM462016(17-(2-methoxyethyl)-N-(pyridin-3-yl)morphinan-3-am...)
Affinity DataIC50: 5nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461965BDBM461965(N-{3-[2-(2-methoxyethoxy)ethoxy]phenyl}-17-methylm...)
Affinity DataIC50: 5nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461962BDBM461962((6β)-6-(2-methoxyethoxy)-17-methylmorphinan-3...)
Affinity DataIC50: 5nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461978BDBM461978((6β)-6-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}-...)
Affinity DataIC50: 5nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461960BDBM461960(N-(3-methoxyphenyl)-17-methylmorphinan-3-amine | ...)
Affinity DataIC50: 5nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461974BDBM461974(17-methyl-N-(pyridin-3-yl)morphinan-3-amine | US1...)
Affinity DataIC50: 5nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461959BDBM461959(N-(4-methoxyphenyl)-17-methylmorphinan-3-amine | ...)
Affinity DataIC50: 5nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 462021BDBM462021(17-(oxetan-2-ylmethyl)morphinan-3-ol | US10766864...)
Affinity DataIC50: 5nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 462037BDBM462037(3-hydroxy-17-(2-methoxyethyl)morphinan | US107668...)
Affinity DataIC50: 5nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 462034BDBM462034(17-[2-(2-methoxyethoxy)ethyl]-N-(5-fluoro-pyridin-...)
Affinity DataIC50: 55nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461967BDBM461967(N-{4-[2-(2-methoxyethoxy)ethoxy]phenyl}-17-methylm...)
Affinity DataIC50: 55nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 462031BDBM462031((4aR,5R,12bR)-15-methyl-2,3,4,4a,5,6-hexahydro-1H-...)
Affinity DataIC50: 55nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461995BDBM461995(17-methyl-N-[6-(2,5,8,11,14-pentaoxahexadecan-16-y...)
Affinity DataIC50: 55nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461961BDBM461961(N-(2-methoxyphenyl)-17-methylmorphinan-3-amine | ...)
Affinity DataIC50: 55nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461993BDBM461993(3-(1H-imidazol-1-yl)-17-methylmorphinan | US10766...)
Affinity DataIC50: 55nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461958BDBM461958(1-(4-methoxyphenyl)-3-(17-methylmorphinan-3-yl)ure...)
Affinity DataIC50: 55nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 462023BDBM462023(17-(2-methoxyethyl)-N-(pyridin-4-yl)morphinan-3-am...)
Affinity DataIC50: 55nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50212299BDBM50212299((1S,9R,10R)-5-amino-20-methyl-6-thia-4,20-diazapen...)
Affinity DataIC50: 55nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461989BDBM461989(N-{6-[2-(2-methoxyethoxy)ethoxy]pyridin-3-yl}-17-m...)
Affinity DataIC50: 55nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 462018BDBM462018(17-(oxetan-3-ylmethyl)morphinan-3-ol | US10766864...)
Affinity DataIC50: 55nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461984BDBM461984(17-methyl-N-(pyrimidin-5-yl)morphinan-3-amine | U...)
Affinity DataIC50: 55nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461953BDBM461953(4-(2-methoxyethoxy)-17-methylmorphinan-3-ol | US1...)
Affinity DataIC50: 55nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461985BDBM461985((4bR,8aR,9R)—N-(5-(2,5,8,11,14-pentaoxahexade...)
Affinity DataIC50: 55nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461982BDBM461982(3-(3-furyl)-17-methylmorphinan | US10766864, Exam...)
Affinity DataIC50: 55nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461948BDBM461948(17-[2-(2-methoxyethoxy)ethyl]morphinan-3-ol | US1...)
Affinity DataIC50: 55nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461979BDBM461979(N-{5-[2-(2-methoxyethoxy)ethoxy]pyridin-3-yl}-17-m...)
Affinity DataIC50: 55nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 462011BDBM462011((4aR,5R,11bR)-14-methyl-1,2,3,4,4a,5,6,10-octahydr...)
Affinity DataIC50: 55nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461977BDBM461977(17-methyl-N-(1,3-thiazol-2-yl)morphinan-3-amine |...)
Affinity DataIC50: 55nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461942BDBM461942((6α)-6-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}-...)
Affinity DataIC50: 55nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461975BDBM461975(17-methyl-3-(1H-pyrazol-4-yl)morphinan | US107668...)
Affinity DataIC50: 55nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50341308BDBM50341308(N-methyl-3-aminothiazolo-morphinan | CHEMBL1766021...)
Affinity DataIC50: 55nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 462005BDBM462005((5α)-5-{2-[2-(2-methoxyethoxy)ethoxy]ethoxy}-...)
Affinity DataIC50: 55nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461970BDBM461970(N-[2-(2-methoxyethoxy)ethyl]-17-methylmorphinan-3-...)
Affinity DataIC50: 550nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461971BDBM461971(tert-butyl (17-methylmorphinan-3-yl)carbamate | U...)
Affinity DataIC50: 550nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 462035BDBM462035(N-((4bR,8aR,9R)-11-(2-(2-methoxyethoxy)ethyl)-6,7,...)
Affinity DataIC50: 550nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461968BDBM461968(N-(17-methylmorphinan-3-yl)methanesulfonamide | U...)
Affinity DataIC50: 550nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461969BDBM461969(N-(4-methoxyphenyl)-17-methylmorphinan-3-carboxami...)
Affinity DataIC50: 550nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461966BDBM461966(N-{2-[2-(2-methoxyethoxy)ethoxy]phenyl}-17-methylm...)
Affinity DataIC50: 550nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461964BDBM461964(2-[2-(2-methoxyethoxy)ethoxy]-N-(17-methylmorphina...)
Affinity DataIC50: 550nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 462028BDBM462028(17-[2-(2-methoxyethoxy)ethyl]-N-(pyridin-4-yl)morp...)
Affinity DataIC50: 550nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 462022BDBM462022(1-(2-methoxyethyl)-3-((4aR,5R,11bR)-14-methyl-2,3,...)
Affinity DataIC50: 550nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461987BDBM461987(17-methyl-N-(pyridazin-4-yl)morphinan-3-amine | U...)
Affinity DataIC50: 550nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461980BDBM461980(17-methyl-N-(pyridin-4-yl)morphinan-3-amine | US1...)
Affinity DataIC50: 550nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461981BDBM461981(17-methyl-N-(pyrimidin-4-yl)morphinan-3-amine | U...)
Affinity DataIC50: 550nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 50138010BDBM50138010(3-Amino-N-methylmorphinan | CHEMBL48420 | US107668...)
Affinity DataIC50: 550nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 462036BDBM462036((4bR,8aR,9R)-3-(furan-3-yl)-11-(2-(2-methoxyethoxy...)
Affinity DataIC50: 550nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461973BDBM461973(N-(17-methylmorphinan-3-yl)-2,5,8,11,14,17-hexaoxa...)
Affinity DataIC50: 550nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

TargetMu-type opioid receptor(Human)
Nektar Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 461938BDBM461938(3-methoxy-17-[2-(2-methoxyethoxy)ethyl]morphinan-6...)
Affinity DataIC50: 550nMAssay Description:Affinities of various compounds were measured in vitro using competitive radioligand binding assays. Serial dilutions of test compounds were incubate...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/26/2021
Entry Details
US Patent

Displayed 1 to 50 (of 106 total ) | Next | Last >>
Jump to: